North America Dry Eye Syndrome Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Drug, By Dosage, By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Online Pharmacy), By Sales Channel, By Product, By Country and Growth Forecast, 2022 - 2028

The North America Dry Eye Syndrome Treatment Market would witness market growth of 3.2% CAGR during the forecast period (2022-2028).

A robust and prospective pipeline has been created as a result of increased R&D efforts for the condition's treatment. This includes items like CyclASol, SURF-100, SURF-200, Pro-ocular, and OCS-02, which are projected to increase the patient population's inventory of available therapy alternatives. Additionally, NOV03 met every clinical target, and its introduction is expected to be soon. Geriatric population growth is anticipated to be a major market driver since older people's eyes produce fewer tears, which causes more evaporation and dryness.

A significant factor driving the growth of the dry eye syndrome treatment market is the rising occurrence of dry eye syndrome and the rising need for dry eye treatment to relieve various symptoms. During the forecast period, there will be opportunities for growth in the markets for eye care products and treatments for dry eye syndrome. This is due to the rapid increase in cases of the condition and the rising adoption of various treatments, such as artificial tears and dry eye treatment drops, for treating multiple symptoms. Additionally, the growing acceptance of femtosecond and excimer ophthalmic lasers for the treatment of dry eye conditions bodes well for the market's future.

In Canada, a prospective, multicenter, observational cross-sectional study was carried out at six locations across the country. This study offered crucial insights into the detrimental effects of DED in the context of Canada. In comparison to people with a moderate or mild condition, those with severe DED had higher indirect and direct costs as well as lower quality of life. Patients with DED and Sjögren's syndrome had worse quality of life (QoL) and higher expenses than those with DED alone. These studies present the possibility of rising cases of DED and its detrimental effects. These will propel the demands for treatment throughout the region, therefore, expediting the expansion of the dry eye syndrome treatment market.

The US market dominated the North America Dry Eye Syndrome Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,558.4 million by 2028. The Canada market is experiencing a CAGR of 5.6% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 4.6% during (2022 - 2028).

Based on Type, the market is segmented into Evaporative Dry Eye Syndrome and Aqueous Deficient Dry Eye Syndrome. Based on Drug, the market is segmented into Restasis, Xiidra, Cequa, Eysuvis and Tyrvaya & Others. Based on Dosage, the market is segmented into Eye drops, Gels, Capsules & Tablets, Eye Solutions and Ointments. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Sales Channel, the market is segmented into OTC and Prescription. Based on Product, the market is segmented into Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: The Global Dry Eye Syndrome Treatment Market is Estimated to reach $6.5 Billion by 2028, at a CAGR of 4.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Services, Inc.), AbbVie, Inc., Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Novartis AG, Sun Pharmaceuticals Industries Ltd., AFT Pharmaceuticals, Santen Pharmaceutical Co., Ltd., Oyster Point Pharma, Inc., OASIS Medical, Inc., and Otsuka Pharmaceutical Co., Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Evaporative Dry Eye Syndrome
• Aqueous Deficient Dry Eye Syndrome

By Drug

• Restasis
• Xiidra
• Cequa
• Eysuvis
• Tyrvaya & Others

By Dosage

• Eye drops
• Gels
• Capsules & Tablets
• Eye Solutions
• Ointments

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

By Sales Channel

• OTC
• Prescription

By Product

• Cyclosporine
• Topical Corticosteroids
• Artificial Tears
• Punctal Plugs
• Oral Omega Supplements
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Johnson & Johnson (Johnson & Johnson Services, Inc.)
• AbbVie, Inc.
• Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
• Novartis AG
• Sun Pharmaceuticals Industries Ltd.
• AFT Pharmaceuticals
• Santen Pharmaceutical Co., Ltd.
• Oyster Point Pharma, Inc.
• OASIS Medical, Inc.
• Otsuka Pharmaceutical Co., Ltd.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Dry Eye Syndrome Treatment Market, by Type
1.4.2 North America Dry Eye Syndrome Treatment Market, by Drug
1.4.3 North America Dry Eye Syndrome Treatment Market, by Dosage
1.4.4 North America Dry Eye Syndrome Treatment Market, by Distribution Channel
1.4.5 North America Dry Eye Syndrome Treatment Market, by Sales Channel
1.4.6 North America Dry Eye Syndrome Treatment Market, by Product
1.4.7 North America Dry Eye Syndrome Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. North America Dry Eye Syndrome Treatment Market by Type
4.1 North America Evaporative Dry Eye Syndrome Market by Country
4.2 North America Aqueous Deficient Dry Eye Syndrome Market by Country

Chapter 5. North America Dry Eye Syndrome Treatment Market by Drug
5.1 North America Restasis Market by Country
5.2 North America Xiidra Market by Country
5.3 North America Cequa Market by Country
5.4 North America Eysuvis Market by Country
5.5 North America Tyrvaya & Others Market by Country

Chapter 6. North America Dry Eye Syndrome Treatment Market by Dosage
6.1 North America Eye drops Market by Country
6.2 North America Gels Market by Country
6.3 North America Capsules & Tablets Market by Country
6.4 North America Eye Solutions Market by Country
6.5 North America Ointments Market by Country

Chapter 7. North America Dry Eye Syndrome Treatment Market by Distribution Channel
7.1 North America Retail Pharmacy Market by Country
7.2 North America Hospital Pharmacy Market by Country
7.3 North America Online Pharmacy Market by Country

Chapter 8. North America Dry Eye Syndrome Treatment Market by Sales Channel
8.1 North America OTC Market by Country
8.2 North America Prescription Market by Country

Chapter 9. North America Dry Eye Syndrome Treatment Market by Product
9.1 North America Cyclosporine Market by Country
9.2 North America Topical Corticosteroids Market by Country
9.3 North America Artificial Tears Market by Country
9.4 North America Punctal Plugs Market by Country
9.5 North America Oral Omega Supplements Market by Country
9.6 North America Others Market by Country

Chapter 10. North America Dry Eye Syndrome Treatment Market by Country
10.1 US Dry Eye Syndrome Treatment Market
10.1.1 US Dry Eye Syndrome Treatment Market by Type
10.1.2 US Dry Eye Syndrome Treatment Market by Drug
10.1.3 US Dry Eye Syndrome Treatment Market by Dosage
10.1.4 US Dry Eye Syndrome Treatment Market by Distribution Channel
10.1.5 US Dry Eye Syndrome Treatment Market by Sales Channel
10.1.6 US Dry Eye Syndrome Treatment Market by Product
10.2 Canada Dry Eye Syndrome Treatment Market
10.2.1 Canada Dry Eye Syndrome Treatment Market by Type
10.2.2 Canada Dry Eye Syndrome Treatment Market by Drug
10.2.3 Canada Dry Eye Syndrome Treatment Market by Dosage
10.2.4 Canada Dry Eye Syndrome Treatment Market by Distribution Channel
10.2.5 Canada Dry Eye Syndrome Treatment Market by Sales Channel
10.2.6 Canada Dry Eye Syndrome Treatment Market by Product
10.3 Mexico Dry Eye Syndrome Treatment Market
10.3.1 Mexico Dry Eye Syndrome Treatment Market by Type
10.3.2 Mexico Dry Eye Syndrome Treatment Market by Drug
10.3.3 Mexico Dry Eye Syndrome Treatment Market by Dosage
10.3.4 Mexico Dry Eye Syndrome Treatment Market by Distribution Channel
10.3.5 Mexico Dry Eye Syndrome Treatment Market by Sales Channel
10.3.6 Mexico Dry Eye Syndrome Treatment Market by Product
10.4 Rest of North America Dry Eye Syndrome Treatment Market
10.4.1 Rest of North America Dry Eye Syndrome Treatment Market by Type
10.4.2 Rest of North America Dry Eye Syndrome Treatment Market by Drug
10.4.3 Rest of North America Dry Eye Syndrome Treatment Market by Dosage
10.4.4 Rest of North America Dry Eye Syndrome Treatment Market by Distribution Channel
10.4.5 Rest of North America Dry Eye Syndrome Treatment Market by Sales Channel
10.4.6 Rest of North America Dry Eye Syndrome Treatment Market by Product

Chapter 11. Company Profiles
11.1 Johnson & Johnson (Johnson & Johnson Services, Inc.)
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental &Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Product Launches and Product Expansions:
11.1.5.2 Approvals and Trials:
11.1.6 SWOT Analysis
11.2 AbbVie, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.3 Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Product Launches and Product Expansions:
11.4 Novartis AG
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Sun Pharmaceuticals Industries Ltd
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Regional Analysis
11.5.4 Research & Development Expenses
11.5.5 Recent strategies and developments:
11.5.5.1 Product Launches and Product Expansions:
11.5.5.2 Approvals and Trials:
11.6 AFT Pharmaceuticals
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Product Launches and Product Expansions:
11.7 Santen Pharmaceutical Co., Ltd.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Regional Analysis
11.7.4 Research & Development Expenses
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.5.2 Approvals and Trials:
11.8 Oyster Point Pharma, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Research & Development Expenses
11.8.4 Recent strategies and developments:
11.8.4.1 Partnerships, Collaborations, and Agreements:
11.8.4.2 Approvals and Trials:
11.9 OASIS Medical, Inc.
11.9.1 Company Overview
11.9.2 Recent strategies and developments:
11.9.2.1 Product Launches and Product Expansions:
11.10. Otsuka Pharmaceutical Co., Ltd.
11.10.1 Company Overview

TABLE 1 North America Dry Eye Syndrome Treatment Market, 2018 - 2021, USD Million
TABLE 2 North America Dry Eye Syndrome Treatment Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Dry Eye Syndrome Treatment Market
TABLE 4 Product Launches And Product Expansions– Dry Eye Syndrome Treatment Market
TABLE 5 Acquisition and Mergers– Dry Eye Syndrome Treatment Market
TABLE 6 Approvals and Trials – Dry Eye Syndrome Treatment Market
TABLE 7 North America Dry Eye Syndrome Treatment Market by Type, 2018 - 2021, USD Million
TABLE 8 North America Dry Eye Syndrome Treatment Market by Type, 2022 - 2028, USD Million
TABLE 9 North America Evaporative Dry Eye Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Evaporative Dry Eye Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Aqueous Deficient Dry Eye Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Aqueous Deficient Dry Eye Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Dry Eye Syndrome Treatment Market by Drug, 2018 - 2021, USD Million
TABLE 14 North America Dry Eye Syndrome Treatment Market by Drug, 2022 - 2028, USD Million
TABLE 15 North America Restasis Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Restasis Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Xiidra Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Xiidra Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Cequa Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Cequa Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Eysuvis Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Eysuvis Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Tyrvaya & Others Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Tyrvaya & Others Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Dry Eye Syndrome Treatment Market by Dosage, 2018 - 2021, USD Million
TABLE 26 North America Dry Eye Syndrome Treatment Market by Dosage, 2022 - 2028, USD Million
TABLE 27 North America Eye drops Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Eye drops Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Gels Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Gels Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Capsules & Tablets Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Capsules & Tablets Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Eye Solutions Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Eye Solutions Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Ointments Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Ointments Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Dry Eye Syndrome Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 38 North America Dry Eye Syndrome Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 39 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Dry Eye Syndrome Treatment Market by Sales Channel, 2018 - 2021, USD Million
TABLE 46 North America Dry Eye Syndrome Treatment Market by Sales Channel, 2022 - 2028, USD Million
TABLE 47 North America OTC Market by Country, 2018 - 2021, USD Million
TABLE 48 North America OTC Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Prescription Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Prescription Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Dry Eye Syndrome Treatment Market by Product, 2018 - 2021, USD Million
TABLE 52 North America Dry Eye Syndrome Treatment Market by Product, 2022 - 2028, USD Million
TABLE 53 North America Cyclosporine Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Cyclosporine Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Topical Corticosteroids Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Topical Corticosteroids Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Artificial Tears Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Artificial Tears Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Punctal Plugs Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Punctal Plugs Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Oral Omega Supplements Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Oral Omega Supplements Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Dry Eye Syndrome Treatment Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Dry Eye Syndrome Treatment Market by Country, 2022 - 2028, USD Million
TABLE 67 US Dry Eye Syndrome Treatment Market, 2018 - 2021, USD Million
TABLE 68 US Dry Eye Syndrome Treatment Market, 2022 - 2028, USD Million
TABLE 69 US Dry Eye Syndrome Treatment Market by Type, 2018 - 2021, USD Million
TABLE 70 US Dry Eye Syndrome Treatment Market by Type, 2022 - 2028, USD Million
TABLE 71 US Dry Eye Syndrome Treatment Market by Drug, 2018 - 2021, USD Million
TABLE 72 US Dry Eye Syndrome Treatment Market by Drug, 2022 - 2028, USD Million
TABLE 73 US Dry Eye Syndrome Treatment Market by Dosage, 2018 - 2021, USD Million
TABLE 74 US Dry Eye Syndrome Treatment Market by Dosage, 2022 - 2028, USD Million
TABLE 75 US Dry Eye Syndrome Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 US Dry Eye Syndrome Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 US Dry Eye Syndrome Treatment Market by Sales Channel, 2018 - 2021, USD Million
TABLE 78 US Dry Eye Syndrome Treatment Market by Sales Channel, 2022 - 2028, USD Million
TABLE 79 US Dry Eye Syndrome Treatment Market by Product, 2018 - 2021, USD Million
TABLE 80 US Dry Eye Syndrome Treatment Market by Product, 2022 - 2028, USD Million
TABLE 81 Canada Dry Eye Syndrome Treatment Market, 2018 - 2021, USD Million
TABLE 82 Canada Dry Eye Syndrome Treatment Market, 2022 - 2028, USD Million
TABLE 83 Canada Dry Eye Syndrome Treatment Market by Type, 2018 - 2021, USD Million
TABLE 84 Canada Dry Eye Syndrome Treatment Market by Type, 2022 - 2028, USD Million
TABLE 85 Canada Dry Eye Syndrome Treatment Market by Drug, 2018 - 2021, USD Million
TABLE 86 Canada Dry Eye Syndrome Treatment Market by Drug, 2022 - 2028, USD Million
TABLE 87 Canada Dry Eye Syndrome Treatment Market by Dosage, 2018 - 2021, USD Million
TABLE 88 Canada Dry Eye Syndrome Treatment Market by Dosage, 2022 - 2028, USD Million
TABLE 89 Canada Dry Eye Syndrome Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 90 Canada Dry Eye Syndrome Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 91 Canada Dry Eye Syndrome Treatment Market by Sales Channel, 2018 - 2021, USD Million
TABLE 92 Canada Dry Eye Syndrome Treatment Market by Sales Channel, 2022 - 2028, USD Million
TABLE 93 Canada Dry Eye Syndrome Treatment Market by Product, 2018 - 2021, USD Million
TABLE 94 Canada Dry Eye Syndrome Treatment Market by Product, 2022 - 2028, USD Million
TABLE 95 Mexico Dry Eye Syndrome Treatment Market, 2018 - 2021, USD Million
TABLE 96 Mexico Dry Eye Syndrome Treatment Market, 2022 - 2028, USD Million
TABLE 97 Mexico Dry Eye Syndrome Treatment Market by Type, 2018 - 2021, USD Million
TABLE 98 Mexico Dry Eye Syndrome Treatment Market by Type, 2022 - 2028, USD Million
TABLE 99 Mexico Dry Eye Syndrome Treatment Market by Drug, 2018 - 2021, USD Million
TABLE 100 Mexico Dry Eye Syndrome Treatment Market by Drug, 2022 - 2028, USD Million
TABLE 101 Mexico Dry Eye Syndrome Treatment Market by Dosage, 2018 - 2021, USD Million
TABLE 102 Mexico Dry Eye Syndrome Treatment Market by Dosage, 2022 - 2028, USD Million
TABLE 103 Mexico Dry Eye Syndrome Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 104 Mexico Dry Eye Syndrome Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 105 Mexico Dry Eye Syndrome Treatment Market by Sales Channel, 2018 - 2021, USD Million
TABLE 106 Mexico Dry Eye Syndrome Treatment Market by Sales Channel, 2022 - 2028, USD Million
TABLE 107 Mexico Dry Eye Syndrome Treatment Market by Product, 2018 - 2021, USD Million
TABLE 108 Mexico Dry Eye Syndrome Treatment Market by Product, 2022 - 2028, USD Million
TABLE 109 Rest of North America Dry Eye Syndrome Treatment Market, 2018 - 2021, USD Million
TABLE 110 Rest of North America Dry Eye Syndrome Treatment Market, 2022 - 2028, USD Million
TABLE 111 Rest of North America Dry Eye Syndrome Treatment Market by Type, 2018 - 2021, USD Million
TABLE 112 Rest of North America Dry Eye Syndrome Treatment Market by Type, 2022 - 2028, USD Million
TABLE 113 Rest of North America Dry Eye Syndrome Treatment Market by Drug, 2018 - 2021, USD Million
TABLE 114 Rest of North America Dry Eye Syndrome Treatment Market by Drug, 2022 - 2028, USD Million
TABLE 115 Rest of North America Dry Eye Syndrome Treatment Market by Dosage, 2018 - 2021, USD Million
TABLE 116 Rest of North America Dry Eye Syndrome Treatment Market by Dosage, 2022 - 2028, USD Million
TABLE 117 Rest of North America Dry Eye Syndrome Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 118 Rest of North America Dry Eye Syndrome Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 119 Rest of North America Dry Eye Syndrome Treatment Market by Sales Channel, 2018 - 2021, USD Million
TABLE 120 Rest of North America Dry Eye Syndrome Treatment Market by Sales Channel, 2022 - 2028, USD Million
TABLE 121 Rest of North America Dry Eye Syndrome Treatment Market by Product, 2018 - 2021, USD Million
TABLE 122 Rest of North America Dry Eye Syndrome Treatment Market by Product, 2022 - 2028, USD Million
TABLE 123 Key information – Johnson & Johnson
TABLE 124 Key information – AbbVie, Inc.
TABLE 125 key information – Bausch + Lomb Corporation
TABLE 126 Key Information – Novartis AG
TABLE 127 Key Information – Sun Pharmaceuticals Industries Ltd.
TABLE 128 Key Information – AFT Pharmaceuticals
TABLE 129 Key Information – Santen Pharmaceutical Co., Ltd.
TABLE 130 Key Information – Oyster Point Pharma, Inc.
TABLE 131 Key Information – OASIS Medical, Inc.
TABLE 132 key information – Otsuka Pharmaceutical Co., Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Johnson & Johnson
FIG 5 SWOT analysis: Johnson & Johnson
FIG 6 Recent strategies and developments: AbbVie, Inc.
FIG 7 Recent strategies and developments: Bausch Health Companies, Inc.
FIG 8 Recent strategies and developments: Sun Pharmaceutical Industries Ltd.
FIG 9 Recent strategies and developments: Santen Pharmaceutical Co., Ltd.
FIG 10 Recent strategies and developments: Oyster Point Pharma, Inc.